Uncontrolled moderate to severe asthma is more than occasional shortness of breath—it often means persistent symptoms, frequent flare-ups, nighttime awakenings, and reliance on rescue inhalers despite regular treatment. This level of asthma can significantly interfere with daily activities, work, sleep, and overall quality of life, and it may increase the risk of emergency visits or hospitalizations.

Clinical research plays a critical role in advancing asthma care by evaluating FDA-approved therapies that may help better control symptoms and reduce exacerbations. Eligible participants may have the opportunity to access these advanced treatment options at no cost, while also contributing to medical research that helps improve outcomes for others living with asthma.